Skip to main content

Table 1 Baseline parameters in patients with CRVO

From: Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety

 

Dexamethasone (n = 20)

Triamcinolone acetonide (n = 20)

Sex (M/F)

12/8

9/11

Mean age (years ± SD)

58.6 ± 10.41

57.9 ± 8.77

Smoker (n)

8

9

Hypertension (n)

4

6

Hyperlipidemia (n)

3

4

Follow up (months ± SD)

6

6

BCVA (logMAR ± SD)

1.06 ± 0.13

0.99 ± 0.15

CMT (µm ± SD)

551 ± 17.16

547.5 ± 13.79

IOP (mmHg ± SD)

16.7 ± 1.16

16.1 ± 2.60

  1. BCVA best-corrected visual acuity, CMT central macular thickness, IOP intraocular pressure, NS not significant